메뉴 건너뛰기




Volumn 24, Issue 4, 2008, Pages

Wavefront-optimized versus wavefront-guided LASIK for myopic astigmatism with the ALLEGRETTO WAVE: Three-month results of a prospective FDA trial

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; ASTIGMATISM; CLINICAL TRIAL; CONTROLLED STUDY; EXCIMER LASER; FEMALE; FOOD AND DRUG ADMINISTRATION; HUMAN; INTERMETHOD COMPARISON; KERATOMILEUSIS; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; MYOPIA; OPEN STUDY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; VISUAL ACUITY;

EID: 42149173278     PISSN: 1081597X     EISSN: None     Source Type: Journal    
DOI: 10.3928/1081597x-20080401-20     Document Type: Article
Times cited : (100)

References (6)
  • 1
    • 42149155907 scopus 로고    scopus 로고
    • Summary of Safety and Effectiveness for a Premarket Approval Application (for the wavefront-optimized correction of myopia with the ALLEGRETTO WAVE). Available at: http://www.fda. gov/cdrh/pdf2/P020050b.pdf. Accessed February 2008.
    • Summary of Safety and Effectiveness for a Premarket Approval Application (for the wavefront-optimized correction of myopia with the ALLEGRETTO WAVE). Available at: http://www.fda. gov/cdrh/pdf2/P020050b.pdf. Accessed February 2008.
  • 2
    • 42149113351 scopus 로고    scopus 로고
    • Summary of Safety and Effectiveness Data for a Supplemental Premarket Approval Application (for the wavefront-optimized correction of myopia with the ALLEGRETTO WAVE). Available at: http://www.fda.gov/cdrh/pdf2/P020050S004b.pdf. Accessed February 2008.
    • Summary of Safety and Effectiveness Data for a Supplemental Premarket Approval Application (for the wavefront-optimized correction of myopia with the ALLEGRETTO WAVE). Available at: http://www.fda.gov/cdrh/pdf2/P020050S004b.pdf. Accessed February 2008.
  • 3
    • 42149124222 scopus 로고    scopus 로고
    • Summary of Safety and Effectiveness Data for a Supplemental Premarket Approval Application (VISX Star S4 Excimer Laser System and WaveScan WaveFront System). Available at: http:// www.fda.gov/ohrms/dockets/dailys/04/july04/ 072004/03m-0333-cr00001-02-summaryofsafety-vol1.pdf. Accessed February 2008.
    • Summary of Safety and Effectiveness Data for a Supplemental Premarket Approval Application (VISX Star S4 Excimer Laser System and WaveScan WaveFront System). Available at: http:// www.fda.gov/ohrms/dockets/dailys/04/july04/ 072004/03m-0333-cr00001-02-summaryofsafety-vol1.pdf. Accessed February 2008.
  • 4
    • 42149145140 scopus 로고    scopus 로고
    • Bausch & Lomb Incorporated Technolas 217z Zyoptix System for Personalized Vision Correction. Available at:, Accessed February 2008
    • Bausch & Lomb Incorporated Technolas 217z Zyoptix System for Personalized Vision Correction. Available at: http://www. fda.gov/cdrh/pdf/ P990027S006c.pdf. Accessed February 2008.
  • 6
    • 0032903958 scopus 로고    scopus 로고
    • Functional vision and corneal changes after laser in situ keratomileusis determined by contrast sensitivity, glare testing and corneal topography
    • Holladay JT, Dedeja DR, Chang J. Functional vision and corneal changes after laser in situ keratomileusis determined by contrast sensitivity, glare testing and corneal topography. J Cataract Refract Surg. 1999;25:663-669.
    • (1999) J Cataract Refract Surg , vol.25 , pp. 663-669
    • Holladay, J.T.1    Dedeja, D.R.2    Chang, J.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.